{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Baker E"],"funding":["National Institute for Health Research (NIHR)","Academy of Medical Sciences"],"pagination":["3-10"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6913574"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["1"],"pubmed_abstract":["<h4>Introduction</h4>Wide local excision and adjuvant radiotherapy is the standard of care for early breast cancer. For large tumours, however, mastectomy is frequently recommended as conventional breast-conserving techniques often result in poor cosmetic outcomes. Therapeutic mammaplasty (TM) may extend the boundaries of breast-conserving surgery by combining breast reduction and mastopexy techniques with tumour excision, preserving a natural breast shape and avoiding the need for mastectomy. The prevalence of this operative option among surgeons in the UK and its success rate are unknown. The TeaM study is a multicentre prospective study that aims to investigate the practice and outcomes of TM.<h4>Methods and analysis</h4>Breast centres performing TM will be invited to participate throug"],"journal":["International journal of surgery protocols"],"pubmed_title":["The TeaM (<i>T</i>h<i>e</i>r<i>a</i>peutic <i>M</i>ammaplasty) study: Protocol for a prospective multi-centre cohort study to evaluate the practice and outcomes of therapeutic mammaplasty."],"pmcid":["PMC6913574"],"funding_grant_id":["CL-2012-25-503","PB-PG-0214-33065","AMS-SGCL8-Potter"],"pubmed_authors":["Fairbrother P","Kim B","Basu N","Rattay T","Trickey A","Mammary Fold Academic and Research Collaborative","Aggarwal S","Williams K","Turton P","Potter S","TeaM Steering Group","Baker E","Achuthan R","Macmillan RD","Gardiner MD","Sutton R","Holcombe C","Jain A","Murphy J","Remoundos D","Brock L","Ives C"],"additional_accession":[]},"is_claimable":false,"name":"The TeaM (<i>T</i>h<i>e</i>r<i>a</i>peutic <i>M</i>ammaplasty) study: Protocol for a prospective multi-centre cohort study to evaluate the practice and outcomes of therapeutic mammaplasty.","description":"<h4>Introduction</h4>Wide local excision and adjuvant radiotherapy is the standard of care for early breast cancer. For large tumours, however, mastectomy is frequently recommended as conventional breast-conserving techniques often result in poor cosmetic outcomes. Therapeutic mammaplasty (TM) may extend the boundaries of breast-conserving surgery by combining breast reduction and mastopexy techniques with tumour excision, preserving a natural breast shape and avoiding the need for mastectomy. The prevalence of this operative option among surgeons in the UK and its success rate are unknown. The TeaM study is a multicentre prospective study that aims to investigate the practice and outcomes of TM.<h4>Methods and analysis</h4>Breast centres performing TM will be invited to participate throug","dates":{"release":"2016-01-01T00:00:00Z","publication":"2016","modification":"2025-04-04T20:45:52.001Z","creation":"2021-02-25T09:44:40Z"},"accession":"S-EPMC6913574","cross_references":{"pubmed":["31851757"],"doi":["10.1016/j.isjp.2016.08.001"]}}